These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 36246594)
1. Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma. Chen M; Wu GB; Hua S; Zhao ZF; Li HJ; Luo M Front Genet; 2022; 13():907859. PubMed ID: 36246594 [No Abstract] [Full Text] [Related]
2. Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma. Chen H; Hou G; Lan T; Xue S; Xu L; Feng Q; Zeng Y; Wang H Heliyon; 2024 Sep; 10(18):e37403. PubMed ID: 39309864 [TBL] [Abstract][Full Text] [Related]
3. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma. Zhou P; Lu Y; Zhang Y; Wang L Front Oncol; 2021; 11():661758. PubMed ID: 34277410 [TBL] [Abstract][Full Text] [Related]
4. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976 [No Abstract] [Full Text] [Related]
5. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma. Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A Front Genet; 2022; 13():916024. PubMed ID: 36110223 [No Abstract] [Full Text] [Related]
6. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status. Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A Front Genet; 2022; 13():898507. PubMed ID: 35754846 [No Abstract] [Full Text] [Related]
7. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer. Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X Front Genet; 2022; 13():984696. PubMed ID: 36092933 [No Abstract] [Full Text] [Related]
8. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Gao C; Zhou G; Cheng M; Feng L; Cao P; Zhou G Front Genet; 2022; 13():956094. PubMed ID: 36330438 [No Abstract] [Full Text] [Related]
9. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL Front Oncol; 2020; 10():780. PubMed ID: 32587825 [No Abstract] [Full Text] [Related]
10. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ Front Oncol; 2021; 11():738477. PubMed ID: 34568075 [TBL] [Abstract][Full Text] [Related]
11. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma. Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472 [TBL] [Abstract][Full Text] [Related]
12. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420 [TBL] [Abstract][Full Text] [Related]
13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
16. A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. Wang J; Shen B; Liu X; Jiang J Front Genet; 2022; 13():985191. PubMed ID: 36267408 [TBL] [Abstract][Full Text] [Related]
17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316 [TBL] [Abstract][Full Text] [Related]
19. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma. Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268 [TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]